Ultrasound Guided Erector Spinae Block Versus Thoracic Para-vertebral

Status Recruiting

Clinical Trial Summary

Open renal surgeries are associated with substantial postoperative pain, pain relief in patients undergoing this procedure is usually provided either by thoracic epidural analgesia (EA) or by systemic analgesics. EA is a very useful option for the management of postoperative pain in patients undergoing abdominal surgeries, but the risks and contraindications linked to EA like hypotension, headache, nerve damage or infection may limit its use. Systemic analgesics in the form of opioid analgesics may give rise to side effects like nausea ,vomiting , constipation , allergy or drowsiness and often provide insufficient analgesia. Hence, other methods of postoperative pain management are desired. Sensory level target according to the incision site Flank (T9-T11) , Thoraco-abdominal (T7-T12 ) and Trans-abdominal (T6-T10). Ultrasound (US) guided erector spinae plane (ESP) block is one of the interfascial plane blocks that target the dorsal and ventral rami of the spinal nerves. Although there is no sufficient evidence for the spread of local anesthetic to the ventral rami, recent reports demonstrated effective postoperative analgesia after thoracic and lumbar surgeries affecting both the ventral and dorsal rami. Paravertebral block (PVB) is a technique where a local anesthetic is deposited into a space found on both sides of the spine, called the paravertebral space. It is a block with a dermatomal distribution of pain relief depending on the level of the spine at which the block is sited and the quantity and type of deposited local anesthetic. PVB is effective for pain relief in the thoracic, abdominal and limb regions. primary aim was to compare postoperative opioid consumption rates at 24 h. Secondary end points were to compare pain scores and hemodynamic variables.

Clinical Trial Description

This was randomized, controlled, single-blinded study, conducted in urology operating theatre, Al-Azhar university hospital. Forty eight patients of both sex and aged from 21-65 years in period between February 2022 to January 2023 scheduled for elective open renal surgeries under general anesthesia were enrolled in this study. The procedure was explained to the patient and informed consent was signed after his agreement then the patient was classified to one of three groups ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05890248
Study type	Observational
Source	Azhar University
Contact	mohamed Aboelsuod, MD
Phone	00201091945931
Email	abosoad.mohamed2017@gmail.com
Status	Recruiting
Phase
Start date	February 1, 2023
Completion date	February 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03672110` - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen	Phase 3
Completed	`NCT01545531` - Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance	N/A
Recruiting	`NCT05700903` - Contributions to Hypertension With Androgen Deprivation Therapy	Phase 4
Completed	`NCT03717883` - ADPKD Alterations in Hepatic Transporter Function
Withdrawn	`NCT04556721` - A Pharmacokinetic Study of Sugammadex in Dialysis Patients	Phase 1
Recruiting	`NCT04078750` - PLATO - Medication Adherence in Transplant Recipients	N/A
Not yet recruiting	`NCT04531124` - Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
Completed	`NCT03107195` - Biokinetics Study of Tc-99m DMSA in Pediatric Molecular Imaging
Completed	`NCT03463148` - Validation of a Sensor for Non-Invasive Measurements
Recruiting	`NCT03578523` - Renal MR Feasibility in Renal Disease
Withdrawn	`NCT01468259` - A Multi-Center, Open-Label Study	Phase 1
Completed	`NCT01256983` - Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation	Phase 0
Completed	`NCT06070337` - H-Guard Pilot Safety Evaluation in Haemodialysis Patients	N/A
Completed	`NCT05593211` - Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures	N/A
Completed	`NCT03242343` - VasQ External Support for Arteriovenous Fistula	N/A
Completed	`NCT03438123` - Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera	N/A
Completed	`NCT01334333` - Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients	Phase 4
Recruiting	`NCT05443321` - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes	N/A
Completed	`NCT04407182` - Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19	Phase 2
Not yet recruiting	`NCT04834089` - Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ultrasound Guided Erector Spinae Block Versus Thoracic Para-vertebral Block Versus Quadratus Lamborum Block in Open Renal Surgeries

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms